SARS-CoV-2, the virus that causes the syndrome COVID-19, has swept the planet over the last 9 months. In a relatively short time, tens of millions of people have been infected and hundreds of thousands have died. Although much remains unknown, early scientific and epidemiologic data has provided insights into how this virus transmits, how the syndrome will present, who may be more likely to become very ill from the virus, and what immunity may linger. Many potential treatments are in clinical trials, with some very close to complete FDA approval, and vaccine trials are underway. Most importantly, there is now a good understanding of what we can do as a society to decrease transmission and begin to open businesses, schools, and communities safely.
Three Key Takeaways from Dr. Rizza’s Presentation:
- Understand the mode of transmission and the clinical syndrome of COVID
- Appreciate the state of treatment development and current therapeutic options
- Understand the state of vaccine development and measures we can take now to decrease infection rates
About Our Speaker
Dr. Stacey Rizza is the Executive Medical Director for International Academic Affairs at Mayo Clinic. She is an Infectious Disease physician at Mayo Clinic in Rochester, Minnesota. Dr. Rizza has been involved in laboratory-based research, clinical research, educational initiatives, and has maintained a busy clinical practice. She is a Professor of Medicine and previous Chair of the Mayo HIV Clinic.Dr. Rizza currently serves as the Associate Dean of the Mayo Clinic School of Health Sciences, the Associate Director for Diversity and Inclusion, Mayo Clinic Transplant Center, as well as President of the Mayo Clinic Staff.
Dr. Rizza has held NIH grants and received a patent for her work on HIV and HCV mediated apoptosis. She is the Chair of the National Comprehensive Cancer Network (NCCN) / African Collaboration for the HIV and Cancer Treatment Guidelines Committee, a member of workgroups within The International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), and has served on committees and held roles within the Infectious Disease Society of America, the World Health Organization (WHO), and the Center for Disease Control (CDC). Dr. Rizza has also consulted with businesses on the creation of cleaning and disinfection protocols to keep customers and employees safe and healthy.
Dr. Rizza graduated with a degree in Biochemistry from Haverford College and received her Medical Degree from the Mayo Clinic Alix School of Medicine. She did an Internal Medicine Residency and Infectious Disease Fellowship at the Mayo Clinic School of Graduate Medical Education, followed by a Post-doctoral Fellowship in HIV and HCV Immunology at the University of California, San Francisco.
WHEN: Thursday, September 10th, 12:30-2:00 p.m. MDT–Mountain Daylight Time
WHERE: Online. This will be a Virtual Event through GoToWebinar
REGISTER: In order to offset expenses associated with our presentation and to continue promoting a quality product, there is a $15 charge for this event.
RSVP for this month’s event by clicking the appropriate link below.